Cancer News

Cancer News By sherri.place

Web

Images

News

November 24, 2009

members login here

Focus Channels

  Cancer
  Genetics
  Biotech
  Pharmaceutical Industry
  Biological sciences

Participate

Build a News Circle

Receive News Briefings

Add this Circle to favorites

Share this News Circle

Subscribe to this News Circle

Cancer

Delcath Systems, Inc. Sponsors Satellite Session at World Meeting of Melanoma/Skin
Reuters - 3 Hours ago
NEW YORK, Nov. 24 /PRNewswire-FirstCall/ -- Delcath Systems, Inc., (Nasdaq: DCTH) a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver,

Delcath Systems, Inc. Sponsors Satellite Session at World Meeting PR Newswire via MSN Money

all 1 news articles >> Add Comment

AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor
Houston Chronicle - 2 Hours ago
Primary efficacy endpoint has been met for patients with advanced-stage or recurrent endometrial cancer QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (AEZS;TSX:AEZ) (the 'Company'),

AEterna Zentaris Announces Positive Results for Phase 2 Study PR Newswire via MSN Money

AEterna Zentaris (AEZS) Announces Phase 2 Results of AEZS-108 Endometrial Cancer Street Insider

all 12 news articles >> Add Comment

AEterna Zentaris Reveals Positive Efficacy Data From Phase 2 Study With AEZS-108
RTTNews.com - 2 Hours ago
(RTTNews) - AEterna Zentaris Inc. (AEZS: News , AEZ.TO) announced positive efficacy data from Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108, formerly AN-152, in patients with advanced Add Comment

CombinatoRx Oncology Programs to Be Highlighted at ASH 2009
Globe Investor - 2 Hours ago
CAMBRIDGE, Mass. (Business Wire) -- CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that two abstracts highlighting data on its A2A and Beta-2 Adrenergic Receptor Agonist oncology programs have Add Comment

Cancer patients to sue hospital
BBC - 4 Hours ago
Eighteen women were wrongly told they did not have breast cancer Seven women are taking legal action against a hospital where they were wrongly given the all-clear for breast cancer following screening Add Comment

UPDATE 1-Norway's Clavis signs $380 mln cancer drug deal
Reuters - 6 Hours ago
* Development deal with U.S.-based Clovis Oncology * Deal value could rise due to royalties * Clavis stock up over 60 pct (Adds details, comments, share price) OSLO, Nov 24 (Reuters) - Norwegian pharmaceutical

SHARES IN NORWAY'S CLAVIS RISE 58 PCT AFTER IT SIGNS $380 MLN CANCER DEAL Forbes.com

all 1 news articles >> Add Comment

Genetics

U.K. cops arrest people â??just for the DNAâ??
MSNBC - 4 Hours ago
LONDON - Britain has built the world's biggest DNA database without proper political debate and police routinely arrest people just to get their DNA profiles onto the system, the genetics watchdog said

Police arrests 'made to get DNA' BBC

British police arresting people â??just for the DNA,' watchdog warns Globe and Mail

all 31 news articles >> Add Comment

Worries over DNA tests done by police
BBC - 7 Hours ago
The database has helped solve 32,200 crimes - 0.7% of all crime Police should not routinely DNA test everyone they arrest, the government's genetic advisers have concluded. The Human Genetics Commission

Employer's DNA test rule raises legal concerns Business Insurance

DNA testing: call for new rules Channel 4 News

all 3 news articles >> Add Comment

S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria
Cell Research - 2 Hours ago
Cell Research advance online publication, November 24, 2009. doi:10.1038/cr.2009.129 Authors: Saeid Ghavami, Mehdi Eshragi, Sudharsana R Ande, Walter J Chazin, Thomas Klonisch, Andrew J Halayko, Karol Add Comment

Antigen fusion with C3d3 augments or inhibits humoral immunity to AAV genetic vaccines
Immunology and Cell Biology - 2 Hours ago
Immunology and Cell Biology advance online publication, November 24, 2009. doi:10.1038/icb.2009.92 Authors: Grant J Logan, Lina Wang, Maolin Zheng, Ross L Coppel & Ian E Alexander Add Comment

DNA database now about suspects, not offenders
IT Pro UK - 3 Hours ago
The DNA database has moved from a database of offenders to one of suspects, according to a . In a new report, the government's own genetics advisory board has said the DNA database must be debated in Add Comment

Introducing OmniSEC - The Most Flexible, Full-Featured GPC/SEC Software Available
Pharmaceutical Online - 4 Hours ago
A new on-demand presentation from Viscotek, a Malvern company, introduces OmniSEC, the company's highly flexible, powerful and easy-to-use software for gel permeation/size exclusion chromatography (GPC/SEC). Add Comment

Biotech

Bayer CropScience Signs Agreement with GVK Biosciences on Early-Stage Research Projects
Reuters - 3 Hours ago
MONHEIM, Germany & HYDERABAD, India--(Business Wire)-- Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early

Bayer CropScience Signs Agreement with GVK Biosciences on Early-S... Zibb

Bayer Cropscience, GVK Biosciences agree on early-stage research projects Bio Spectrum Asia

all 5 news articles >> Add Comment

The Automation Partnership Collaborates With Major European Biotech
Reuters - 4 Hours ago
Providing a Custom Protein Purification and Concentration System to Reduce Timelines CAMBRIDGE, England--(Business Wire)-- The Automation Partnership (TAP), a world leader in the design and development Add Comment

Biovitrum AB concludes sale of Cambridge Biotechnology Ltd - Zibb...
Zibb - 3 Hours ago
Company: Biovitrum AB (BIOVY) Swedish pharmaceutical company Biovitrum AB (STO:BVT) declared on Tuesday that it has completed the sale of its wholly-owned subsidiary Cambridge Biotechnology Ltd (CBT) Add Comment

Cephalon stock drops after trial data disappoint
Reuters Health - 13 Hours ago
-0400 (Reuters Health) * Reports disappointing results of esophagus drug trial * Cephalon shares drop as much as 10 pct * Cephalon delays decision on Ception acquisition By Toni Clarke BOSTON, (Reuters)

UPDATE 5-Cephalon stock drops after trial data disappoint London South East

all 1 news articles >> Add Comment

Merck Serono Extends Chinese Footprint
Pharmaceutical Technology - 2 Hours ago
Merck Serono has announced plans to extend its global research and development footprint in China by investing more than â?¬150m and building an R&D centre in Beijing. The centre will lead drug development Add Comment

Pharmaceutical Industry

Salix Pharmaceuticals to Present at Piper Jaffray Conference
Forbes.com - 3 Hours ago
BusinessWire - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the Piper Jaffray 21st Annual Health Care Conference in New York, NY on Tuesday, December 1 at

Isis Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference Yahoo! Canada

all 1 news articles >> Add Comment

SectorWatch.biz: Vaccines Projected as Leading Pharma Growth Driv...
Zibb - 3 Hours ago
Company: TapImmune Inc (TPIV) According to several recent reports, the vaccine marketplace will show big gains through 2012 as it emerges as one of the most lucrative sectors in the global pharmaceutical

SectorWatch.biz: Vaccines Projected as Leading Pharma Growth Driver Individual.com

all 1 news articles >> Add Comment

Lightning Round: AT&T, Verizon, Novartis and More1...
CNBC - 12 Hours ago
loading...Â Â Â [VIPÂ Loading...Â Â Â () Â ]: â??Too risky,â? Cramer said. Go with AT&T loading...Â Â Â [TÂ Loading...Â Â Â () Â ] or Verizon Communications loading...Â Â Â [VZÂ Add Comment

Drug firms raise prices ahead of reform
MSNBC - 7 Hours ago
Even as drug makers promise to support Washingtonâ??s health care overhaul by shaving $8 billion a year off the nationâ??s drug costs after the legislation takes effect, the industry has been raising

Drug prices hiked ahead of US medicare reforms Xinhua News Agency

Drug prices raised ahead of US medicare reforms Xinhua News Agency

all 3 news articles >> Add Comment

Bristol-Myers Squibb Up 15.1% Since SmarTrend's Buy Recommendatio...
Zibb - 7 Hours ago
SmarTrend, our proprietary pattern recognition system, called an Uptrend for Bristol-Myers Squibb (NYSE:BMY) on July 30, 2009 at $21.76. Since then, Bristol-Myers Squibb has returned 15.1% as of today's

Asterand Extends Agreement With Bristol-Myers Squibb FDA News

Asterand and Bristol-Myers Squibb extend compound profiling collaboration Proactive Investors.co.uk

all 10 news articles >> Add Comment

UK cost body again rejects Roche bowel cancer drug
Reuters UK - 15 Hours ago
* Avastin deemed not cost-effective by NICE * Agency criticises 'complex' Roche subsidy scheme LONDON, Nov 24 (Reuters) - Britain's healthcare cost-effectiveness watchdog has again rejected Roche's (ROG.VX)

NICE again rejects Roche bowel cancer drug Reuters UK

UK's NICE Rejects Roche's Avastin In Bowel Cancer Morningstar.com

all 3 news articles >> Add Comment

Biological sciences

Chameleon species discovered in snake's mouth
Telegraph - 7 Hours ago
A new species of chameleon was discovered in an African forest living in the mouth of a snake. The tiny lizard came out of the mouth of a twig snake disturbed by Dr Andrew Marshall in Tanzania's Magombera

New species of chameleon discovered... after snake coughs one up in front of scientist Mail Online UK

New species of chameleon discovered in Tanzania Africa Leader

all 10 news articles >> Add Comment

Intersex fish in Potomac remains mystery
Washington Post - 14 Hours ago
In 2003, scientists discovered something startling in the Potomac, from which at least 3 million Washington area residents get their drinking water: Male fish were growing eggs. But six years later, a

Fish deaths remain mystery Witney Gazette

all 1 news articles >> Add Comment

Odd couples of the animal world
New Scientist - 2 Hours ago
With Marty Crump's precise yet jolly prose, Sexy Orchids Make Lousy Lovers puts soap operas to shame Add Comment

Prokaryotic transcriptomics: a new view on regulation, physiology and pathogenicity
Nature Reviews Genetics - 7 Hours ago
Nature Reviews Genetics. doi:10.1038/nrg2695 Authors: Rotem Sorek & Pascale Cossart Add Comment

Maize genome mapped - Premium content
Nature - 15 Hours ago
Hat off to these people working hard on the maize genome sequencing project. This is a great achievement. While the communities are celebrating this breakthrough, Science, Nature, and NSF should investigate Add Comment

Drug-resistant bacteria on increase in U.S.: study
Yahoo! News - 4 Hours ago
WASHINGTON (Reuters) Cases of a drug-resistant bacterial infection known as MRSA have risen by 90 percent since 1999, and they are increasingly being acquired outside hospitals, researchers reported on

Drug-resistant bacteria on increase in US Times Live South Africa

all 1 news articles >> Add Comment



	Already a member? Sign in


	Email Address:
	Password:


Forget your password?

Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms of Use | Privacy Policy | Need Help? | Site Map